IDT Biologika Establishes U.S. Office

IDT Biologika has opened new offices outside Washington, DC in Herndon, VA in response to increased demand for the company’s services in the U.S. market. In Europe, IDT operates pharmaceutical and biological development and manufacturing facilities to supply world markets. Peter Linzmeyer, executive vice president of IDT Biologika Corp., will run the new office. IDT’s expansion into the U.S. market coincides with the recent opening of new filling and packaging facilities in Germany this past January.

According to Dr. Ralf Pfirmann, chief executive officer of IDT Biologika, the establishment of operations in the U.S. will allow the company to support its customers’ operations in the U.S. drug market and to develop closer working relationships with firms in the region. Said Dr. Pfirmann, “IDT Biologika has had an excellent reputation in Europe as one of the premiere outsourcing partners for pharmaceutical companies for over two decades, particularly in the area of biologics. During this time, we have continually improved our facilities through investment and have developed the personnel and business processes commensurate with a global supplier of these services to the industry. The opening of a U.S. location is a logical next step in our growth to become a global supplier of sterile liquid dosage forms.”